Epidemiology and diagnosis of Lyme borreliosis

Annals of Medicine

Volumn 37, Issue 8, 2005, Pages 568-579

  Wilske, Bettina ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Borrelia; Borrelia burgdorferi; Epidemiology; Lyme borreliosis; Microbiological diagnosis; Serology

Indexed keywords

BODY FLUID; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CELL LYSATE; DIAGNOSTIC TEST; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN; IMMUNOBLOTTING; LYME DISEASE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; WHOLE CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; INCIDENCE; LYME DISEASE; SKIN; WORLD HEALTH;

EID: 28844474474     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890500431934     Document Type: Short Survey

References (102)

1. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639-47.
2. Steere AC. Lyme disease. N Engl J Med. 1989;321:586-96.
3. Pfister HW, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet. 1994;343:1013-6.
4. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science. 1982;216:1317-9.
5. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-27.
6. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol. 1999;289:643-52.
7. Wilske B, Steinhuber R, Bergmeister H, Fingerle V, Schierz G, Preac-Mursic V, et al. [Lyme borreliosis in South Germany. Epidemiologic data on the incidence of cases and on the epidemiology of ticks (Ixodes ricinus) carrying Borrelia burgdorferi]. Dtsch Med Wochenschr. 1987;112:1730-6.
8. Asbrink E, Hovmark A, Hederstedt B. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol. 1984;64:506-12.
9. Schmidt R, Kabatzki J, Hartung S, Ackermann R. [Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects]. Dtsch Med Wochenschr. 1985;110:1803-7.
10. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev. 1999;12:633-53.
11. Wilske B, Preac-Mursic V, Göbel UB, Graf B, Jauris S, Soutschek E, et al. An OspA seroryping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol. 1993;31:340-50.
12. Canica MM, Nato F, du ML, Mazie JC, Baranton G, Postic D. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis. 1993;25:441-8.
13. Ohlenbusch A, Matuschka FR, Richter D, Christen HJ, Thomssen R, Spielman A, et al. Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis. 1996;174:421-3.
14. Eiffert H, Ohlenbusch A, Christen HJ, Thomssen R, Spielman A, Matuschka FR. Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis. 1995;171:476-9.
15. van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993;17:708-17.
16. Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, Rössler D, et al. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (Berl). 1996;184:195-201.
17. Eiffert H, Karsten A, Thomssen R, Christen HJ. Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis. 1998;30:265-8.
18. Vasiliu V, Herzer P, Rössler D, Lehnert G, Wilske B. Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol (Berl). 1998;187:97-102.
19. Jaulhac B, Chary-Valckenaere I, Sibilia J, Javier RM, Piemont Y, Kuntz JL, et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum. 1996;39:736-45.
20. Jaulhac B, Heller R, Limbach FX, Hansmann Y, Lipsker D, Monteil H, et al. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J Clin Microbiol. 2000;38:1895-900.
21. Lunemann JD, Zarmas S, Priem S, Franz J, Zschenderlein R, Aberer E, et al. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol. 2001;39:1130-3.
22. Hubalek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidemiol. 1997;13:951-7.
23. Gern L, Hu CM, Kocianova E, Vyrostekova V, Rehacek J. Genetic diversity of Borrelia burgdorferi sensu lato isolates obtained from Ixodes ricinus ticks collected in Slovakia. Eur J Epidemiol. 1999;15:665-9.
24. Michel H, Wilske B, Hettche G, Goettner G, Heimerl C, Reischl U, et al. An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (Berl). 2003;193:219-26.
25. Rauter C, Oehme R, Diterich I, Engele M, Hartung T. Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR. J Clin Microbiol. 2002;40:36-43.
26. Rijpkema S, Golubic D, Molkenboer M, Verbeek-de Kruif N, Schellekens J. Identification of four genomic groups of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in a Lyme borreliosis endemic region of northern Croatia. Exp Appl Acarol. 1996;20:23-30.
27. Peter O, Bretz AG, Bee D. Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland. Eur J Epidemiol. 1995;11:463-7.
28. Demaerschalck I, Ben Messaoud A, De Kesel M, Hoyois B, Lobet Y, Hoet P, et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol. 1995;33:602-8.
29. Ruzic-Sabljic E, Arnez M, Logar M, Maraspin V, Lotric-Furlan S, Cimperman J, et al. Comparison of Borrelia burgdorferi Sensu Lato Strains Isolated from Specimens Obtained Simultaneously from Two Different Sites of Infection in Individual Patients. J Clin Microbiol. 2005;43:2194-200.
30. Olsen B, Duffy DC, Jaenson TG, Gylfe A, Bonnedahl J, Bergstrom S. Transhemispheric exchange of Lyme disease spirochetes by seabirds. J Clin Microbiol. 1995;33:3270-4.
31. Humair P, Gern L. The wild hidden face of Lyme borreliosis in Europe. Microbes Infect. 2000;2:915-22.
32. Kurtenbach K, Sewell HS, Ogden NH, Randolph SE, Nuttall PA. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun. 1998;66:1248-51.
33. Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol. 2001;1:393-401.
34. Fingerle V, Liegl G, Munderloh U, Wilske B. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans. Med Microbiol Immunol (Berl). 1998;187:121-6.
35. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A. 1995;92:2909-13.
36. de Silva AM, Fikrig E. Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg. 1995;53:397-404.
37. Kahl O, Janetzki-Mittmann C, Gray JS, Jonas R, Stein J, de Boer R. Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zentralbl Bakteriol. 1998;287:41-52.
38. Rijpkema SG, Tazelaar DJ, Molkenboer MJ, Noordhoek GT, Plantinga G, Schouls LM, et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin Microbiol Infect. 1997;3:109-16.
39. Wang G, van Dam AP, Dankert J. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with lyme borreliosis. J Clin Microbiol. 1999;37:3025-8.
40. Wilske B. Diagnosis of lyme borreliosis in europe. Vector Borne Zoonotic Dis. 2003;3:215-27.
41. Liang FT, Philipp MT. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect Immun. 1999;67:6702-6.
42. Liang FT, Aberer E, Cinco M, Gern L, Hu CM, Lobet YN, et al. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis. 2000;182:1455-62.
43. Mathiesen MJ, Christiansen M, Hansen K, Holm A, Asbrink E, Theisen M. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol. 1998;36:3474-9.
44. Wilske B, Schriefer M. Borrelia. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. 8th edition Volume 1. Washington, D.C.: ASM Press, 2003: p. 937-54.
45. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18:484-509.
46. Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB, Stanek G, et al. MIQ 12, Lyme-Borreliose. In: Mauch H, Lütticken R, editors. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Munich, Germany: Urban & Fischer Verlag, 2000: p. 1-59.
47. Kaiser R. [Prevention of early summer meningoencephalitis and Lyme borreliosis before and after tick bites]. Dtsch Med Wochenschr. 1998;123:847-53.
48. Preac-Mursic V, Wilske B, Reinhardt S. Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis. 1991;10:1076-9.
49. Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg [A]. 1986;263:112-8.
50. Arnez M, Ruzic-Sabljic E, Ahcan J, Radsel-Medvescek A, Pleterski-Rigler D, Strle F. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Pediatr Infect Dis J. 2001;20:251-5.
51. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol. 1990;28:473-9.
52. Strle F. Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr. 1999;111:911-5.
53. Zore A, Ruzic-Sabljic E, Maraspin V, Cimperman J, Lotric-Furlan S, Pikelj A, et al. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin Wochenschr. 2002;114:606-9.
54. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis. 2001;184:1070-2.
55. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev. 1997;10:185-201.
56. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18:484-509.
57. Asbrink E, Olsson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease. Acta Derm Venereol. 1985;65:43-52.
58. von Stedingk LV, Olsson I, Hanson HS, Asbrink E, Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 1995;14:1-5.
59. Wilske B, Preac-Mursic V. Microbiological diagnosis of Lyme borreliosis. In: Weber K, Burgdorfer W, editors. Aspects of Lyme Borreliosis. Berlin, Heidelberg, Germany and New York, USA: Springer Verlag, 1993: p. 267-300.
60. Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn. 2000;5:139-50.
61. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med. 1994;330:229-34.
62. Centers for Disease Control and Prevention, Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44:590.
63. Johnson BJ, Robbins KE, Bailey RE, Cao BL, Sviat SL, Craven RB, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis. 1996;174:346-53.
64. Wilske B, Fingerle V, Herzer P, Hofmann A, Lehnert G, Peters H, et al. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol (Berl). 1993;182:255-70.
65. Hansen K, Hindersson P, Pedersen NS. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol. 1988;26:338-46.
66. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD, Jr, Philipp MT, Steere AC, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187:1187-99.
67. Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP, et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol. 1999;37:3997-4004.
68. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol. 1999;37:3990-6.
69. Panelius J, Lahdenne P, Saxen H, Carlsson SA, Heikkila T, Peltomaa M, et al. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J Neurol. 2003;250:1318-27.
70. Heikkila T, Seppala I, Saxen H, Panelius J, Yrjanainen H, Lahdenne P. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J Clin Microbiol. 2002;40:453-60.
71. Hauser U, Lehnert G, Lobentanzer R, Wilske B. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol. 1997;35:1433-44.
72. Hauser U, Lehnert G, Wilske B. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin Diagn Lab Immunol. 1998;5:456-62.
73. Robertson J, Guy E, Andrews N, Wilske B, Anda P, Granström M, et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol. 2000;38:2097-102.
74. Dressler F, Ackermann R, Steere AC. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis. 1994;169:313-8.
75. Schulte-Spechtel U, Lehnert G, Liegl G, Fingerle V, Heimerl C, Johnson BJ, et al. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol. 2003;41:1299-303.
76. Wilske B, Habermann C, Fingerle V, Hillenbrand B, Jauris-Heipke S, Lehnert G, et al. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol (Berl). 1999;188:139-44.
77. Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J Clin Microbiol. 2005;43:3602-9.
78. Schulte-Spechtel U, Fingerle V, Goettner G, Rogge S, Wilske B. Molecular analysis of decorin binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene. Int J Med Microbiol. 2005, In press.
79. Wilske B, Schierz G, Preac-Mursic V, von Busch K, Kuhbeck R, Pfister HW, et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis. 1986;153:304-14.
80. Hansen K, Cruz M, Link H. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis. 1990;161:1194-202.
81. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30:197-205.
82. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl. 1993;386:1-75.
83. Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr. 1996;108:741-7.
84. Kristoferitsch W. Neurologic manifestations in Lyme borreliosis. Clin Dermatol. 1993;11:393-400.
85. Asbrink E, Hovmark A, Hederstedt B. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays. Acta Derm Venereol. 1985;65:509-14.
86. Hansen K, Asbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Microbiol. 1989;27:545-51.
87. Lahdenne P, Panelius J, Saxen H, Heikkila T, Sillanpaa H, Peltomaa M, et al. Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens. J Med Microbiol. 2003;52:563-7.
88. Philipp MT, Wormser GP, Marques AR, Bittker S, Martin DS, Nowakowski J, et al. A decline in c6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme borreliosis. Clin Diagn Lab Immunol. 2005;12:1069-74.
89. Peltomaa M, McHugh G, Steere AC. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis. 2003;187:1178-86.
90. Department of Health and Human Services CfDCaP, Caution regarding testing for Lyme disease. MMWR Morb Mortal Wkly Rep. 2005;54:125.
91. Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol. 1995;131:673-7.
92. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med. 1988;319:1441-6.
93. Kalish RS, Wood JA, Golde W, Bernard R, Davis LE, Grimson RC, et al. Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status. J Infect Dis. 2003;187:102-8.
94. Horowitz HW, Pavia CS, Bittker S, Forseter G, Cooper D, Nadelman RB, et al. Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Clin Diagn Lab Immunol. 1994;1:373-8.
95. Coyle PK, Schutzer SE, Belman AL, Krupp LB, Dheng Z. Cerebrospinal fluid immunologic parameters in neurologic Lyme disease. In: Schutzer SE, editor. Lyme disease: Molecular and immunologic approaches. New York, USA: Cold Spring Harbor Laboratory Press, 1992: p. 31-44.
96. Hyde FW, Johnson RC, White TJ, Shelburne CE. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol. 1989;27:58-61.
97. Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001;110:217-9.
98. Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol. 1998;36:2658-65.
99. Karch H, Huppertz HI, Bohme M, Schmidt H, Wiebecke D, Schwarzkopf A. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol. 1994;32:2312-4.
100. Richter D, Schlee DB, Allgower R, Matuschka FR. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol. 2004;70:6414-9.
101. Wilske B, Busch U, Fingerle V, Jauris-Heipke S, Preac M, V, Rössler D, et al. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection. 1996;24:208-12.
102. Wilske B. Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol. 2002;291(Suppl 33): 114-9.